186 related articles for article (PubMed ID: 30445928)
1. Does fibrosis have an impact on survival of patients with hepatocellular carcinoma: evidence from the SEER database?
Liu H; Cen D; Yu Y; Wang Y; Liang X; Lin H; Cai X
BMC Cancer; 2018 Nov; 18(1):1125. PubMed ID: 30445928
[TBL] [Abstract][Full Text] [Related]
2. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis.
Kamarajah SK
Asian J Surg; 2018 Nov; 41(6):551-561. PubMed ID: 29454570
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma.
Lin H; Li X; Liu Y; Hu Y
ANZ J Surg; 2018 Oct; 88(10):E718-E724. PubMed ID: 29399938
[TBL] [Abstract][Full Text] [Related]
5. Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.
Mironov O; Jaberi A; Kachura JR
J Vasc Interv Radiol; 2017 Mar; 28(3):325-333. PubMed ID: 28073607
[TBL] [Abstract][Full Text] [Related]
6. Role of liver-directed local tumor therapy in the management of hepatocellular carcinoma with extrahepatic metastases: a SEER database analysis.
Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):183-189. PubMed ID: 27830958
[TBL] [Abstract][Full Text] [Related]
7. Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.
Parikh ND; Marshall VD; Singal AG; Nathan H; Lok AS; Balkrishnan R; Shahinian V
Hepatology; 2017 Jan; 65(1):122-133. PubMed ID: 27770556
[TBL] [Abstract][Full Text] [Related]
8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic impact on survival in unresectable hepatocellular carcinoma: a survival epidemiology and end results study.
Kokabi N; Xing M; Duszak R; Duszak R; Howard DH; Applegate KE; Camacho JC; Kim HS
Future Oncol; 2016 Jan; 12(2):183-98. PubMed ID: 26690268
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database.
Zhang N; Gu J; Yin L; Wu J; Du MY; Ding K; Huang T; He X
Oncotarget; 2016 Dec; 7(49):81389-81401. PubMed ID: 27835609
[TBL] [Abstract][Full Text] [Related]
13. Deep learning models for predicting the survival of patients with hepatocellular carcinoma based on a surveillance, epidemiology, and end results (SEER) database analysis.
Wang S; Shao M; Fu Y; Zhao R; Xing Y; Zhang L; Xu Y
Sci Rep; 2024 Jun; 14(1):13232. PubMed ID: 38853169
[TBL] [Abstract][Full Text] [Related]
14. Differences in the prognostic value of tumor size on hepatocellular cancer-specific survival stratified by gender in a SEER population-based study.
Zhang W; Jin K; Wang F; Zhangyuan G; Yu W; Liu Y; Zhang H; Zhang P; Sun B
United European Gastroenterol J; 2019 Aug; 7(7):933-941. PubMed ID: 31428418
[TBL] [Abstract][Full Text] [Related]
15. The power of tumor sizes in predicting the survival of solitary hepatocellular carcinoma patients.
Yang A; Xiao W; Chen D; Wei X; Huang S; Lin Y; Zhang C; Lin J; Deng F; Wu C; He X
Cancer Med; 2018 Dec; 7(12):6040-6050. PubMed ID: 30430769
[TBL] [Abstract][Full Text] [Related]
16. Early stage hepatocellular carcinoma in the elderly: A SEER database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
J Geriatr Oncol; 2017 Jul; 8(4):277-283. PubMed ID: 28389117
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
Zhu Q; Yuan B; Qiao GL; Yan JJ; Li Y; Duan R; Yan YQ
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):418-27. PubMed ID: 26823044
[TBL] [Abstract][Full Text] [Related]
20. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
